Pages that link to "Q40144002"
Jump to navigation
Jump to search
The following pages link to Zollinger-Ellison Syndrome: Current Concepts and Management (Q40144002):
Displaying 50 items.
- ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter (Q24647752) (← links)
- Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies (Q24647838) (← links)
- Diagnostic and Treatment Approaches for Refractory Peptic Ulcers (Q26799215) (← links)
- Hepatic gastrinoma (Q28261310) (← links)
- Multiple duodenal ulcer: natural history and pathophysiology (Q34528641) (← links)
- Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome (Q34557489) (← links)
- Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients (Q35598674) (← links)
- Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome (Q35922060) (← links)
- Treatment of Zollinger-Ellison syndrome (Q36285347) (← links)
- Diagnosis of Zollinger-Ellison syndrome: increasingly difficult (Q36351873) (← links)
- Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome (Q36484987) (← links)
- Role of acid suppressants in patients with Zollinger-Ellison Syndrome (Q36517000) (← links)
- Hypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for Zollinger-Ellison syndrome (Q37015684) (← links)
- Review article: Strategies to determine whether hypergastrinaemia is due to Zollinger-Ellison syndrome rather than a more common benign cause (Q37396001) (← links)
- Use of omeprazole in patients with Zollinger-Ellison syndrome (Q37674520) (← links)
- Zollinger-Ellison Syndrome (Q37781501) (← links)
- New and Emerging Syndromes due to Neuroendocrine Tumors (Q37846916) (← links)
- Primary hepatic gastrinoma: Report of a case and review of literature (Q37878890) (← links)
- Clinical recognition and evaluation of peptic ulcer disease (Q37968461) (← links)
- Current diagnosis and management of Zollinger-Ellison syndrome (Q38729136) (← links)
- Drug-Induced Vitamin B12 Deficiency: A Focus on Proton Pump Inhibitors and Histamine-2 Antagonists (Q38926407) (← links)
- PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success. (Q39299620) (← links)
- Diagnosis and treatment of Zollinger-Ellison syndrome (Q39524669) (← links)
- Advances in the management of patients with Zollinger-Ellison syndrome. (Q40523235) (← links)
- Optimizing acid suppression for treatment of acid-related diseases (Q40595569) (← links)
- Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I. (Q40712327) (← links)
- Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome. (Q40841123) (← links)
- Zollinger-Ellison syndrome. Recognition and management of acid hypersecretion (Q41107158) (← links)
- Surgery for peptic ulceration associated with hypergastrinaemia (Q41356168) (← links)
- Gastrointestinal endocrine tumours. Gastrinoma (Q41439948) (← links)
- Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study (Q41696042) (← links)
- Neuroendocrine islet cell tumour producing gastrin and ACTH in a patient with calcifying chronic pancreatitis (Q42055702) (← links)
- The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells (Q42465840) (← links)
- Helicobacter pylori and Zollinger-Ellison syndrome (Q42475243) (← links)
- A retrospective study of the usefulness of acid secretory testing (Q42482218) (← links)
- Idiopathic gastric acid hypersecretion. Comparison with Zollinger-Ellison syndrome (Q42495216) (← links)
- Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists (Q42503583) (← links)
- Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome (Q42506563) (← links)
- Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome. (Q42509657) (← links)
- Bleeding duodenal ulcer. Role of gastric acid hypersecretion (Q43434503) (← links)
- Evaluation of the acute abdomen. When to consult a surgeon (Q43467068) (← links)
- Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? (Q43742703) (← links)
- Current approach to the management of tumoral process in patients with gastrinoma (Q44076786) (← links)
- Localization and resection of gastrinomas in Zollinger-Ellison syndrome (Q44462609) (← links)
- The Zollinger-Ellison syndrome. A collective surgical experience (Q46042442) (← links)
- Definition for idiopathic gastric acid hypersecretion. A statistical and functional evaluation (Q46269541) (← links)
- Atypical endocrine tumors of the lung: a histologic, ultrastructural, and clinical study of 19 cases (Q46365961) (← links)
- Ranitidine therapy in patients with idiopathic gastric acid hypersecretion. A prospective study (Q46373295) (← links)
- Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions. (Q46901207) (← links)
- Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy (Q47424929) (← links)